Leading the Fight Against
African Swine Fever Virus
AI-Driven Vaccine &
Antibody Development
OUR STORY
At Kermode Biotechnologies, we are dedicated to pioneering solutions in animal health, with a focus on combating the African Swine Fever Virus (ASFV). Founded on the principles of innovation and scientific excellence, our team is developing novel vaccines that leverages unique protein antigen subunits to elicit strong immune responses in swine. With roots in both New York and Shenzhen, we bridge the gap between cutting-edge research and practical applications. Our mission is to safeguard global swine populations, enhance food security, and support farmers worldwide. Through relentless pursuit of groundbreaking research, Kermode Biotechnologies stands at the forefront of animal disease prevention, transforming challenges into opportunities for a healthier future.
ABOUT
AFRICAN SWINE FEVER VIRUS
The spread ASFV has devastated the commercial swine industries in Europe, Russia, and most recently China, resulting in billions of lost dollars and the loss of a major nutritional staple. It is a matter of time before ASFV infiltrates North American livestock.
ASFV is a highly contagious
viral pathogen that swiftly
infects swine livestock.
Once the swine are infected, the virus
will kill the animal within 24 to 48 hours.
The mortality rate for
ASFV-infected animals is 100%.
ASFV STATISTICS
OUR APPROACH
We are utilizing computational approaches to define vulnerable targets in viral structure, genetic composition and replication cycles. Once these targets are defined, we deploy state-of-the-art antibody discovery platforms to isolate therapeutic candidates with the highest potential to protect livestock against viral infections. This approach will allow Kermode to identify strong antibody therapeutics and construct vaccine candidates with long-lasting in vivo responses.
Regulatory
Submission
Partnering
ANTIBODY AND ANTI-VIRAL PROTEIN DEVELOPMENT FOR THERAPEUTICS / VACCINES
ANTIBODY & PROTEIN INVENTION
ANTIBODY & PROTEIN CHARACTERIZATION
PROTEIN EXPRESSION
SWINE STUDIES
MARKET APPROVAL
ASFV THERAPEUTIC
DEVELOPMENT PIPELINE
OUR PARTNERS
At Kermode Biotechnologies, we believe in the power of collaboration to drive innovation and success. Our partners play a crucial role in advancing our mission to develop cutting-edge solutions for the prevention and control of the African Swine Fever Virus (ASFV). By working together, we leverage each other's strengths, expertise, and resources to accelerate the development and distribution of our groundbreaking vaccine technology.
By partnering with industry leaders in biotechnology, pharmaceuticals, and animal health, we enhance our capabilities in research, development, and manufacturing. These partnerships allow us to scale our production processes and ensure the availability of our vaccine to swine herds across the globe.